A Domestic Outbreak of Bacterial Dysentery Caused by Extended-Spectrum β-Lactamase(ESBL)-producing Shigella sonnei
![]() |
Lim, Hyun Taek
(Department of Pediatrics College of Medicine, Konkuk University)
Lee, So Hee (Department of Pediatrics College of Medicine, Konkuk University) Lee, Jung Hwa (Department of Pediatrics College of Medicine, Konkuk University) Kim, Jeong Eun (Department of Pediatrics College of Medicine, Konkuk University) Kim, Kyo Sun (Department of Pediatrics College of Medicine, Konkuk University) Jeong, Eun Ju (Department of Microbiology College of Medicine, Konkuk University) Lee, Seung Hyun (Department of Microbiology College of Medicine, Konkuk University) Kang, Chang Gyu (Local Corporation Chungju Medical Center) Hong, Seong Jin (Department of Pediatrics College of Medicine, Konkuk University) |
1 | The Korea Center for Disease Control and Prevention. Recent trends in national notifiable diseases occurrence based on the data of 2003. Communicable Diseases Monthly Report 2004;15:129-37 |
2 | MEGA. molecular evolutionary genetics analysis[computer program]. version 1.01. Pennsylvania State University, University Park; 1993. |
3 | Cleary TG. Shigella. In : Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, editors. Textbook of pediatric infectious diseases. 5th ed. Philadelphia : WB Saunders Co, 2004:1459-69 |
4 | Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med 2004;350:38-47 DOI ScienceOn |
5 | Salam MA, Bennish ML. Therapy for shigellosis. I. Randomized double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 1988;113:901-7 DOI PUBMED |
6 |
Rice L. Evolution and clinical importance of extended-spectrum |
7 |
Colodner R. Extended-spectrum |
8 |
Neu HC, Saha G, Chin NX. Comparative in vitro activity and |
9 | Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis 1997;25:1196-204 DOI ScienceOn |
10 | The Zimbabwe, Bangladesh, South africa(Zimbasa) Dysentery Study Group. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Pediatr Infect Dis J 2002;21:1136-41 DOI PUBMED ScienceOn |
11 | Salam MA, Dhar U, Khan WA, Bennish ML. Randomized comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet 1998;352:522-7 DOI ScienceOn |
12 |
The Korea Center for Disease Control and Prevention. Extended-spectrum |
13 |
Pai H, Choi EH, Lee HJ, Hong JY, Jacoby GA. Identification of CTX-M-14 extended-spectrum |
14 | Prado D, Liu H, Velasquez T, Cleary TG. Comparative efficacy of pivmecillinam and cotrimoxazole in acute shigellosis in children. Scand J Infect Dis 1993;25:713-9 DOI ScienceOn |
15 | Oldfield EC 3rd, Wallace MR, The role of antibiotics in the treatment of infectious diarrhea. Gastroenterol Clin North Am 2001;30:817-36 DOI ScienceOn |
16 | Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-51 DOI ScienceOn |
17 | Bennish ML, Salam MA, Haider R, Barza M. Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 1990;162:711-6 DOI ScienceOn |
18 |
Jacoby GA. Epidemiology of extended-spectrum |
19 |
Bush K. New |
20 | Rakita RM, Jacques-Palaz K, Murray BE. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother 1994;38:1915-21 DOI ScienceOn |
21 | Chatterjee A, Moland ES, Thomson KS. Cefdinir : An oral alternative to parenteral cephems. Diagn Microbiol Infect Dis 2005;51:259-64 DOI ScienceOn |
22 | Kim SH, Kim JY, Kang YH, Park YK, Lee BK. Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea. J Clin Microbiol 2004;42:5264-9 DOI ScienceOn |
23 | The Korea Center for Disease Control and Prevention. The first domestic outbreak of ESBL producing Shigella sonnei. Communicable Diseases Monthly Report 2004;15:252 |
24 | Kabir I, Butler T, Khanam A. Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in placebo-controlled trial. Antimicrob Agents Chemother 1986;29:645-8 DOI ScienceOn |
25 | Stapleton P, Wu PJ, King A, Shannon K, French G, Phillips I. Incidence and mechanism of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 1995;39:2478-83 DOI ScienceOn |
26 | The Korea Center for Disease Control and Prevention. The outbreak of ESBL producing Shigella sonnei. Communicable Diseases Monthly Report 2005;16:1-5 |
27 | Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis : III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med 1992;117:727-34 DOI ScienceOn |
28 |
Pitout JD, Sanders CC, Sanders WE Jr. Antimicrobial resistance with focus on |
29 | Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics : worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J 1997;16:127-9 DOI ScienceOn |
30 | Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 2003;47:559-62 DOI ScienceOn |
31 | Nakamura T, Komatsu M. Susceptibility of ESBL-producing Escherichia coli and Klebsiella pneumoniae to various antibiotic agents. Jpn J Antibiot 2005;58:1-10 DOI PUBMED ScienceOn |
32 | Ho PL, Shek RH, Chow KH, Duan RS, Mak GC, Lai EL, et al. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J Antimicrob Chemother 2005;55:326-32 |
33 | Salam MA, Seas C, Khan WA, Bennish ML. Treatment of shigellosis : IV. Cefixime is ineffective in shigellosis in adults. Ann Intern Med 1995;123:505-8 DOI ScienceOn |
34 | Dupont HL. Shigella species(Bacillary dysentery). In : Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia : Elsevier Churchill Livingstone Co, 2004:2655-61 |
35 | Martin JM, Pitetti R, Maffei F, Tritt J, Smail K, Wald ER. Treatment of shigellosis with cefixime : two days vs. five days. Pediatr Infect Dis J 2000;19:522-6 DOI ScienceOn |
36 | Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections due to extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae : risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004;48:4574-81 DOI ScienceOn |
37 | Rupp ME, Fey PD. Extended spectrum beta-lactamase(ESBL)-producing Enterobacteriacea : considerations for diagnosis, prevention and drug treatment. Drugs 2003;63:353-65 DOI ScienceOn |
38 | Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis : V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med 1997;126:697-703 DOI ScienceOn |
39 | Helvaci M, Bektaslar D, Ozkaya B, Yaprak I, Umurtak B, Ertugrul A. Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children. Acta Paediatr Jpn 1998;40:131-4 DOI |
40 | Shanks GD, Smoak BL, Aleman GM, Oundo J, Waiyaki PG, Dunne MW, et al. Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Acute dysentery study group. Clin Infect Dis 1999;29:942-3 DOI ScienceOn |
![]() |